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A B S T R A C T
In the eye, the retinal pigment epithelium (RPE) adheres to a complex protein matrix known as Bruch's mem-
brane (BrM). The aim of this study was to provide enriched conditions for RPE cell culture through the produc-
tion of a BrM-like matrix. Our hypothesis was that a human RPE cell line would deposit an extracellular ma-
trix (ECM) resembling BrM. The composition and structure of ECM deposited by ARPE19 cells (ARPE19-ECM)
was characterized. To produce ARPE19-ECM, ARPE19 cells were cultured in the presence dextran sulphate.
ARPE19-ECM was decellularized using deoxycholate and characterized by immunostaining and western blot
analysis. Primary human RPE and induced pluripotent stem cells were seeded onto ARPE19-ECM or geltrex
coated surfaces and examined by microscopy or RT-PCR. Culture of ARPE19 cells with dextran sulphate pro-
moted nuclear localization of SOX2, formation of tight junctions and deposition of ECM. ARPE19 cells deposited
ECM proteins found in the inner layers of BrM, including fibronectin, vitronectin, collagens IV and V as well
as laminin-alpha-5, but not those found in the middle elastic layer (elastin) or the outer layers (collagen VI).
ARPE19-ECM promoted pigmentation in human RPE and pluripotent stem cell cultures. Expression of RPE65 was
significantly increased on ARPE19-ECM compared with geltrex in differentiating pluripotent stem cell cultures.
ARPE19 cells deposit ECM with a composition and structure similar to BrM in the retina. Molecular cues present
in ARPE19-ECM promote the acquisition and maintenance of the RPE phenotype. Together, these results demon-
strate a simple method for generating a BrM-like surface for enriched RPE cell cultures.
1. Introduction
Somatic cells require a complex plethora of signals from their mi-
croenvironment to maintain their identity in the body. Disruption of
these signals through injury or disease can cause pathological changes
in cellular phenotypes, such as transdifferentiation or neoplastic trans-
formation. Standard methods for primary cell culture involve remov-
ing cells from their tissue-specific microenvironments and introducing
them into a new environment in which essential signals are provided
by media supplemented with serum or growth factors. Since many cell
types do not readily adhere to tissue culture plastic, culture surfaces
often require coating with extracellular matrix (ECM) proteins to pro
mote adherence and support cell growth. Standard cell culture condi-
tions, in which cells are cultured on tissue culture plastic in a bath of
cell culture media, have been likened to the physiological condition of
oedema [5]. Under these conditions, many cell types undergo growth
adaptation, resulting in non-physiological phenotypes that may influ-
ence experimental outcomes. Although these changes may be mitigated
by providing the correct growth factors and ECM formulations, full re-
capitulation of complex tissue microenvironments in vitro remains a sig-
nificant challenge for cell culture research.
An alternative approach to generating tissue-specific microenviron-
ments involves the use of cultured cell lines to deposit ECM. Several
authors have demonstrated that ECM is deposited by a number of dif-
ferent cultured cell lines, including fibroblasts, endothelial cells and
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retinal pigment epithelial cells (RPE) [10,13,3]. It has been shown that
ECM deposition can be greatly enhanced by supplementation of me-
dia with macromolecular crowding agents, such as Ficoll or dextran
sulphate [5]. In vivo, cells reside in a crowded microenvironment, sur-
rounded with high densities of macromolecules. In a crowded environ-
ment, local concentrations of growth factors and ECM precursors are
effectively increased by lower rates of diffusion away from the source,
promoting autocrine signaling and ECM deposition. In contrast, stan-
dard cell culture conditions fail to provide a crowded microenviron-
ment, resulting in diffusion of growth factors and ECM proteins away
from their source and a reduction in the ability of cells to create their
own niche. Supplementation of cell culture media with crowding agents
such as dextran sulphate has been shown to recapitulate the crowded
environment, promoting autocrine signaling and ECM deposition [5].
Using detergents, cell-deposited ECMs can be decellularized to produce
surfaces that enable cell adhesion and promote cell growth [5]. Fibrob-
last-deposited ECM was previously shown to promote the growth of
pluripotent stem cell cultures [1], while ECM derived from bone mar-
row stromal cells supported self-renewal and multipotency in human
mesenchymal stem cell cultures [8]. In this study, ECM derived from the
human retinal pigment epithelial (RPE) cell line, ARPE19, was charac-
terized and evaluated as a surface for RPE cell culture and differentia-
tion.
In the retina, the basal surface of the RPE is attached to a complex
protein matrix, 2–5 µm thick, known as Bruch's membrane (BrM). BrM
is comprised of 5 distinct layers, each containing a different array of ex-
tracellular matrix (ECM) proteins [7]. The outer and inner layers of BrM
form the basal lamina of the choroid and RPE, respectively, and cover
a middle elastic layer comprised of elastin. BrM provides structural sup-
port to the RPE cell layer and enables diffusion of nutrients and waste
products into and out of the retina. The innermost layers of BrM are rich
in ECM proteins such as fibronectin, vitronectin, laminin, and collagen
IV, that bind to β1-integrins expressed on the basal surface of RPE cells
[6].
Although commercial ECM coatings used in RPE cell culture, such
as matrigel, laminin, vitronectin or fibronectin enable attachment of
RPE cells to tissue culture plastic [11,12,14], they do not provide an
organized, tissue-specific ECM that accurately recapitulates the struc-
ture and composition of BrM. Since the role of ECM in specifying and
maintaining cellular phenotypes is becoming increasingly clear [2],
the aim of this study was to produce a BrM-like matrix that can be
used to recapitulate the native RPE microenvironment in vitro and pro-
vide enriched conditions for RPE cell culture. Our hypothesis was that
the human RPE cell line ARPE19 would deposit an ECM resembling
BrM. In this study, the composition and structure of ECM deposited by
ARPE19 cells was characterized. The data presented demonstrate a sim-
ple method for producing decellularized ARPE19 cell-derived ECM sur-
faces (ARPE19-ECM) that promote an RPE phenotype in primary human
RPE cells and pluripotent stem cells.
2. Methods
2.1. Production of ARPE19 cell-derived extracellular matrix
Unless otherwise specified, media, medium supplements and
reagents used for cell cultures were purchased from Thermo Fisher
Scientific, (Waltham, MA, USA). The human RPE cell line ARPE19
(American Type Culture Collection, Manassas, VA, USA) was cultured
in DMEM supplemented with 10% fetal calf serum (DMEM/FCS). To
generate cell-derived extracellular matrix (ECM) coatings, ARPE19 cells
were seeded at 80–90% confluence in DMEM/FCS (uncrowded condi-
tions). Upon reaching confluence, the media was changed to DMEM/
FCS supplemented with the macromolecular crowder dextran sulphate
(200 μg/ml) and ascorbic acid (30 μg/ml) (Sigma-Aldrich, St. Louis,
MO, USA) (crowded conditions). Confluent ARPE19 monolayers were
cultured for indicated times with half media changes twice per week.
Wells were then decellularized by three successive incubations with
0.5% deoxycholate (Sigma) in distilled H⁠2O for 15 min at room temper-
ature, followed by three successive washes with PBS to remove cell de-
bris and residual detergents. Wells then were treated for 20 min with 10
U/ml of TURBO DNase (Thermo Fisher Scientific, Invitrogen) in PBS to
remove residual DNA then washed three times in PBS.
2.2. Dissection of human posterior eye cups and primary RPE culture
Human posterior eye cups were obtained from the Lions Eye Bank
(WA, Australia, https://www.lei.org.au/services/lions-eye-bank/) after
written informed consent was obtained from next of kin and within
12 h of enucleation. The use of cadaveric human tissues was approved
by the Sir Charles Gardiner Hospital Human Research Ethics Commit-
tee (Approval number 2012-090). Uveal sacs containing choroid, retina
and vitreous were dissected out of posterior cups, opened with relax-
ing cuts and the neuroretina and vitreous removed from the underly-
ing RPE-choroid. Patches of RPE adhering to the retina were collected
and pooled with RPE cells scraped from the inner aspect of the choroid.
RPE-free retinal tissue was collected for protein harvesting (see Section
2.6). Isolated RPE was dissociated with TrypLE Express (Thermo Fisher
Scientific) for 30 min at 37 °C, pelleted by centrifugation and resus-
pended in culture media. Live cell numbers were determined by Try-
pan blue exclusion before RPE cells were plated into 24-well plates
(50,000 cells per well) and cultured in DMEM supplemented with 10%
FCS. To promote RPE cell adherence, culture plates were coated with
the commercial ECM formulations Geltrex (Thermo Fisher Scientific)
and Vitronectin (Stem Cell Technologies, Vancouver, BC, Canada) or
ARPE19-ECM.
2.3. Human induced pluripotent stem cell culture
A human episomal induced pluripotent stem cell (iPSC) line was
obtained from Thermo Fisher Scientific (A18945). Human iPSC cells
were cultured under feeder free conditions on geltrex-coated plates
in TeSer-E8 media according to the manufacturer's recommendations
(Stem Cell Technologies).
2.4. Preparation of decellularized of choroid tissues
Choroid-RPE tissues were dissected from human posterior eye cups
as described above. After removal of the retina, choroid-RPE tissues was
placed into 50 ml of 0.5% deoxycholate in H⁠2O and incubated on a
rocker at 4 °C. The dexoycholate solution was removed and replaced
three times over a 48 h period and decellularized choroid-RPE tissues
then transferred to a new tube containing 50 ml distilled H⁠2O. Decellu-
larized choroid-RPE tissues were washed three times in H⁠20 at 4 °C over
a 48 h period, then divided into pieces for wholemount immunostaining
analysis. Decellularization was confirmed by the absence of DAPI stain-
ing (Supp Fig. 4).
2.5. Immunostaining
Cells or ECM were fixed with 4% Paraformaldehyde (PFA) in PBS
for 15 min at 37 °C then washed three times with PBS. Cells were then
incubated with chilled methanol (−20 °C) for 10 min at room temper-
ature and washed in PBS three times. Cells were incubated with block-
ing buffer (PBS, 5% goat serum, 0.3% Triton-X100) for one hour at
room temperature. Primary antibodies were diluted in blocking buffer
and added to the cells for overnight incubation at 4 °C. Cells were then
washed three times with PBS before the addition of fluorophore conju-
gated secondary antibodies and the nuclear stain DAPI (1 μg/ml). Pri
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mary mouse antibodies used in this study included: anti-MITF;
anti-N-cadherin; anti-laminin-α5; anti-collagen VI; anti-pan-cytokeratin
(Abcam, Cambridge, England, UK); and anti-βIII-tubulin (Promega,
Fitchburg, WI, USA). Primary rabbit antibodies included: anti-SOX2;
anti-ZO1; anti-Fibronectin; anti-Vitronectin; anti-collagen V; anti-colla-
gen IV; anti-elastin (Abcam). Secondary antibodies used in this study
were: Goat anti-Mouse-AlexaFluor⁠546 and Goat anti-Rabbit-Alexa-
Fluor⁠488 (Thermo Fisher Scientific), both used at a dilution of 1:500. Flu-
orescent microscopy was performed on an Olympus IX70 inverted fluo-
rescence microscope (for culture plates) or the Olympus BX60 fluores-
cence microscope (for slides) and imaged using Olympus DP-Controller
3.1.1.267 acquisition software (Olympus Corporation, Tokyo, Japan).
Negative controls in which primary antibodies were omitted were rou-
tinely performed for each experiment.
2.6. Western blot
For protein extraction, retinal cells and tissue were lysed with RIPA
buffer containing protease inhibitor cocktails (Sigma) for 20–30 min on
ice. Samples were centrifuged to remove debris and the supernatant
collected for determination of protein concentration using the Micro
BCA™ Protein Assay Kit (Thermo Fisher Scientific). For collection of
ECM proteins from 24 well plates, decellularized ARPE19-ECM was im-
mersed in 0.2 ml of 5% acetic acid and incubated at 4 °C overnight.
The acetic acid solution was collected and wells then incubated in lysis
buffer (125 mM Tris-HCl, pH 6.8; 0.1% SDS; 10% glycerol; 1% dithio-
threitol; Proteinase Inhibitor Cocktail) at 37 °C for one hour. Wells were
then scraped and the lysis buffer with matrix proteins was collected. The
lysis-scraping-collection step was performed twice and protein samples
pooled. Acetic acid samples were combined with scraped lysis buffer
samples and mixed with 5 volumes of acetone. The mixture was kept
at −20 °C overnight then centrifuged at 8000g for 20 min at 4 °C.
The protein pellet was resuspended with in buffer containing 20 mM
Tris-HCl (pH 7.6), 100 mM NaCl, and 1 mM EDTA. Protein concen-
tration was determined using Micro BCA™ Protein Assay Kit (Thermo
Fisher Scientific) and samples stored at −20 °C.
Unless otherwise stated, all reagents, pre-cast polyacrylamide gels
and membranes used for protein electrophoresis and western blot analy-
sis system were purchased from Thermo Fisher Scientific. For Western
blot analysis, 20 μg of total protein was mixed with 1×NuPAGE LDS
Sample Buffer, 1×NuPAGE® Sample Reducing Agent containing 50 mM
dithiothreitol, then heated at 70 °C for 10 min. Denatured protein sam-
ples were loaded onto a NuPAGE 4–12% Bis-Tris Gels and electrophoret-
ically separated at 200 V for 30 min in 1×NuPAGE MES SDS Running
Buffer. Separated proteins in the gels were transferred with Original
iBlot Gel Transfer Device onto nitrocellulose membranes at 20 V for
6 min. Blotted membranes were washed with TPBS (0.05% Tween20,
50 mM Tris-HCl, 150 mM NaCl), and incubated with blocking buffer
(2% BSA in TPBS) for 60 min. Membranes were then incubated with
primary antibodies in blocking buffer overnight at 4 °C. Membranes
were then washed five times in TPBS and incubated for 1 h with Goat
Anti-Rabbit Poly-HRP secondary antibody or Goat Anti-Mouse Poly-HRP
secondary antibody (1:20,000). Protein bands were detected using the
SuperSignal West Pico Chemiluminescent Substrate according to the
manufacturer's instruction. Membranes were imaged using the Bio-Rad
ChemiDoc XRS⁠+ system. Primary antibodies used in this study included:
Rabbit anti-SOX2, Mouse anti-GAPDH, Rabbit anti-Fibronectin and Rab-
bit anti-Vitronectin (Abcam).
2.7. Quantitative PCR
Total RNA was extracted from cells using the RNeasy Plus Micro Kit
(Qiagen, Hilden, Germany). Total RNA was then quantified using the
Nanodrop 2000 spectrophotometer (Thermo Fisher Scientific).
First-strand cDNA was synthesized using 0.5–1 μg of RNA and RT⁠2 First
Strand Kit (Qiagen) according to the supplier's protocol. RT-PCR reac-
tions for human PAX6, MITF, OTX2, RPE65 and GAPDH were performed
in a 25 μl mixture containing 1 μl (15-20 ng) of cDNA, primers (0.4 μM)
and RT⁠2 SYBR-Green qRT-PCR Master Mix (Qiagen) in the CFX Connect
Real-Time PCR thermocycler (Bio-Rad, Hercules, CA, USA). Gene ex-
pression values for each mRNA species were determined using the ΔΔCt
method [9] normalized against the GAPDH expression value from each
mRNA sample. Sequences for primers used in this study are listed in
Supplementary Table 1.
3. Results
3.1. Macromolecular crowding enhances nuclear localization of SOX2 and
tight junction formation in ARPE19 cells
ARPE19 cells were cultured under control conditions or in the pres-
ence of dextran sulphate and ascorbic acid (crowded conditions). Im-
munostaining for the transcription factor SOX2 revealed nuclear local-
ization in crowded cultures, while control cultures displayed only cy-
toplasmic immunoreactivity (Supp Fig. 1A). In contrast, immunostain-
ing for the transcription factor MITF was similar in both control and
crowded cultures, with nuclear localization observed under both condi-
tions (Supp Fig. 1B).
In crowded cultures, N-cadherin immunostaining revealed confluent
monolayers consisting of polygonal cells with tight cell-cell junctions.
In comparison, monolayers cultured under control conditions contained
elongated cells and N-cadherin immunoreactivity was associated with
an interdigitated cell-cell interface (Supp Fig. 1A). Similarly, immunos-
taining for the tight junction protein ZO1 revealed tight junctions in
crowded cultures, while few ZO1 labeled tight junctions were observed
in control cultures. ZO1 immunolabelling was also detected in the nu-
clei of ARPE19 cells in both control and crowded cultures (Supp Fig.
1B). Together, these results demonstrate that macromolecular crowding
can partially reverse the growth adapted phenotype of cultured ARPE19
cells.
3.2. Deposition of extracellular matrix by ARPE19 cells
To examine the deposition of extracellular matrix in vitro, ARPE19
cells were cultured in crowded conditions for 1–4 weeks. Culture wells
were then decellularized using deoxycholate to produce cell-free
ARPE19 cell-derived ECM surfaces. Immunostaining of ARPE19-ECM
demonstrated robust deposition of fibronectin in crowded cultures,
while control cultures deposited little fibronectin (Supp Fig. 1C). Decel-
lularization was assessed by microscopy and βIII-tubulin immunostain-
ing. No intact cells or βIII-tubulin immunopositive cell fragments were
detected on decellularized ARPE19-ECM (Supp Fig. 2).
To examine the composition of ARPE19-ECM, decellularized matri-
ces were subjected to immunostaining analysis using a panel of antibod-
ies targeting ECM proteins. Decellularized ARPE19-ECM displayed im-
munoreactivity for proteins found in the inner layers of Bruch's mem-
brane, including fibronectin, vitronectin, collagens IV, and V (Fig. 1)
as well as laminin-α5 (Supp Fig. 3). ECM was deposited across the en-
tire culture well floor within one week of culture and continued to ac-
cumulate for up to one month. Fibronectin immunoreactivity accumu-
lated more rapidly than immunoreactivity to vitronectin and laminin-α5
(Supp Fig. 3). ARPE19-ECM displayed no immunoreactivity for collagen
VI or elastin (Fig. 1), which are present in the outer and middle layers
of BrM, respectively.
In decellularized choroid-BrM whole mounts, double immunolabel-
ing for fibronectin and laminin-α5 revealed a polygonal network of fi
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Fig. 1. Composition of decellularized ARPE19-ECM. Immunostaining of ARPE19-ECM demonstrated the presence of fibronectin, vitronectin, collagens IV, V and VI and elastin.
bronectin fibrils surrounding discrete laminin-α5 deposits (Supp Fig. 4).
Similarly, fibronectin immunolabeling of ARPE19-ECM revealed a dense
polygonal network of fibrils. In contrast, the commercial ECM geltrex
displayed sparse, punctate fibronectin immunoreactivity (Fig. 2). These
results show that ECM deposited by ARPE19 cells mimics the composi-
tion and microstructure of BrM deposited by RPE cells in the eye.
3.3. Post-translational modification of ECM proteins by ARPE19 cells
Analysis of protein lysates from decellularized ARPE19-ECM by
Western blot demonstrated increasing fibronectin deposition from 7 to
18 days in culture. After 7 days, fibronectin immunoreactivity was as-
sociated with a 260 kDa band, however the mobility of the band in-
creased at later timepoints, indicating post-translational modifications
Fig. 2. Comparison of ECM surface structure. Immunostaining of ARPE19-ECM (left panels) or geltrex coated tissue culture plastic (middle panels) or decellularized choroid-BrM whole-
mounts (right panels) using antibodies for fibronectin demonstrated networks of fibrils in ARPE19-ECM and BrM, but not in geltrex coated surfaces. Scale bars indicate 50 µm.
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of the fibronectin protein occur during matrix development in vitro (Fig.
3A, left panel). Interestingly, the 260 kDa fibronectin-immunopositive
band was present in protein lysates from cultured ARPE19 cells while
protein lysates from freshly isolated BrM contained only the smaller
band, which was approximately 160–180 kDa in size (Fig. 3A, right
panel).
Western blot analysis of human retinal and RPE protein lysates for
vitronectin revealed a single band approximately 10 kDa in size, which
was also detected in ARPE19 cells grown under crowded and control
conditions. In comparison, a commercial vitronectin sample contained
at least 5 anti-vitronectin immunoreactive bands, with the majority of
vitronectin immunolabelling attributed to a single band approximately
100 kDa in size. Minor vitronectin immunoreactivity was also observed
Fig. 3. Analysis of ECM proteins by Western Blot. A: Western blot analysis for fi-
bronectin in ARPE19-ECM protein lysates produced after 7, 14 or 18 days of ARPE19
cell culture under crowded conditions (left panel) or from protein lysates harvested from
adult human Bruch's membrane (BrM) and ARPE19 cells cultured without crowders (right
panel). B: Western blot analysis for vitronectin in protein lysates harvested from fresh hu-
man retina (Ret) and RPE cells (RPE), ARPE19 cells cultured under non-crowded (ARPE)
or crowded (MMC) conditions, and a commercial vitronectin solution (Vitro).
in 4 other bands, 260, 75, 55 and 40 kDa in size, however the smaller
10 kDa band was not detected in the commercial sample (Fig. 3B).
These results indicate that in the human retina and ARPE19 cells, vit-
ronectin is produced in its ‘clipped’ form, in which the 75 kDa propep-
tide has undergone cleavage into two fragments (65 kDa and 10 kDa in
size) held together by a disulphide bridge. [4] No single chain (75 kDa)
vitronectin was detected in protein extracts from RPE, retina or ARPE19
cells (Fig. 3B). Together, these results demonstrate that ECM proteins
produced by ARPE19 cells undergo similar post-translational modifica-
tions to those found in the retina.
3.4. ARPE19-ECM promotes RPE differentiation
Primary human RPE cells isolated from the same donor eyes at-
tached to surfaces coated with geltrex, vitronectin or ARPE19-ECM, but
not to uncoated tissue culture plastic. Culture of primary human RPE
cells for one month on either geltrex or vitronectin matrices resulted in
the dedifferentiation of RPE cells, indicated by cell elongation and loss
of pigmentation. RPE cells grown on vitronectin failed to achieve con-
fluence, while those cultured on geltrex or ARPE19-ECM formed con-
fluent monolayers. In comparison with monolayers formed on geltrex,
RPE cells cultured on ARPE19-ECM displayed a more differentiated phe-
notype, retaining a pigmented phenotype for over 1 month in culture
(Fig. 4). These results indicate that ARPE19-ECM contains molecular
cues that promote the maintenance of the RPE cell phenotype.
To further examine the RPE promoting properties of ARPE19-ECM,
RPE differentiation from human induced pluripotent stem cells (iPSC)
was compared on ARPE19-ECM and geltrex surfaces. Human iPSC cul-
tured on ARPE19-ECM formed large pigmented colonies that were sur-
rounded by non-pigmented, polygonal epithelial cells (Fig. 5A). In con-
trast, iPSC cultured on geltrex formed a thin monolayer consisting of
non-pigmented fibroblast-like cells (Fig. 5B). Expression of the ocular
transcription factors PAX6, MITF and OTX2 was similar in iPSC cultured
on ARPE19-ECM or geltrex. In contrast, the RPE marker RPE65 was sig-
nificantly increased in iPSC cultured on ARPE19-ECM, compared with
geltrex (Fig. 5C). Together, these results indicate ARPE19-ECM contains
signals that promote the differentiation of RPE cells from pluripotent
stem cells.
4. Discussion
ECMs throughout the body display high degrees of tissue speci-
ficity, supplying complex chemical and physical cues and constraints
that work together to specify cellular phenotypes. The presence of an
appropriate ECM is critical for maintaining these phenotypes in vivo
and in vitro [2]. While commercial ECM formulations provide permis-
sive surfaces for the attachment of a wide variety of cells, they remain
a poor substitute for the native basement membranes present in vivo. In
this study, a simple method for generating BrM-like surfaces in vitro was
shown to enrich RPE cell culture conditions and promote RPE cell dif-
ferentiation from pluripotent stem cells.
Fig. 4. Culture of adult human RPE cells on ARPE19-ECM. Primary human RPE cells were seeded into wells coated with geltrex, vitronectin or ARPE19-ECM. One month after seeding,
only cells cultured on ARPE19-ECM retained a pigmented phenotype.
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Fig. 5. Differentiation of pluripotent stem cells on ARPE19-ECM. A: Human iPSC cultured on ARPE19-ECM produced pigmented spheres (upper panel, inset shows high magnification
view) and polygonal epithelial monolayers (lower panel) after 4 weeks. B: In contrast, human iPSC cultured on geltrex produced non-pigmented monolayers (upper panel) consisting of
elongated fibroblastic cells (lower panel). C: Quantitative RT-PCR demonstrated similar induction of PAX6, MITF and OTX2 mRNA expression in iPSC cultured on ARPE19-ECM (black
bars) or geltrex (grey bars) for 2 weeks. In contrast, RPE65 expression was significantly increased in iPSC cultured on ARPE19-ECM compared with iPSC cultured on geltrex (p=0.018).
Gene expression values were normalized against GAPDH and expressed as a fold change relative to undifferentiated iPSC. Each bar represents the mean of 3 independent experiments.
Error bars indicate standard deviation.
4.1. Use of macromolecular crowding for ECM production
Removal of RPE cells from their subretinal niche and expansion
in culture is often accompanied by a loss of mature RPE character-
istics. Growth adapted RPE cells, such as the ARPE19 cell line and
long-term primary cultures, cease production of melanin, lose their api-
cal-basal polarity and adopt hypertrophic, elongated cell morphologies
(Supp Fig. 1). In this study, ARPE19 cells retained their growth-adapted
phenotype when cultured under standard conditions employing DMEM
media with serum supplementation, indicated by elongated cell mor-
phologies with interdigitated cell-cell junctions containing N-cadherin
but little ZO1. Under standard conditions, expression of the transcrip-
tion factor SOX2 was exclusively cytoplasmic (Supp Fig. 1). Addition
of the macromolecular crowder dextran sulphate resulted in dramatic
changes in ARPE19 cell morphology. Under crowded culture condi
tions, ARPE19 monolayers contained tightly packed polygonal cells with
tight junctions containing ZO1 and N-cadherin, as well as SOX2 im-
munopositive nuclei (Supp Fig. 1). These data indicate that macromole-
cular crowders such as dextran sulphate can partially reverse the growth
adaptations observed in cultured RPE cells.
4.2. Composition and microstructure of ARPE19-ECM
In addition to inducing changes in cell morphology and protein lo-
calization, dextran sulphate also promoted the deposition of ECM (Fig.
1C). The assembly of ECM under crowded culture conditions allows
cells to manufacture their own microenvironments. In the retina, BrM
forms a major component of the RPE microenvironment. During devel-
opment, human BrM initially forms around 6–7 weeks of gestation at
the interface between the RPE layer and the extraocular mesenchyme.
Early BrM consists of two basal lamina layers; the outer layer, derived
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from mesenchymal cells, and the inner layer, which is the basement
membrane produced by RPE cells. By 11–12 weeks of gestation, colla-
gen and elastin secretion by fibroblasts and endothelial cells leads to the
formation of the inner and outer collagenous layers (ICL and OCL, re-
spectively) on either side of the middle elastic layer [6]. After 2 weeks
of culture in crowded conditions, ARPE19-ECM contained a number of
proteins found in the ICL and RPE basal lamina (RBL) of BrM, including
fibronectin, vitronectin, collagens IV and V as well as laminin- α5 (Fig.
1, Supp Fig. 3).
Fibronectin is a common component of basement membranes and
forms a dense meshwork in the ICL of BrM [6,7]. In decellularized
choroidal-BrM wholemounts, fibronectin immunostaining revealed a
network of fibrils (Fig. 2) that surrounded discrete spots of laminin-α5
deposition (Supp Fig. 4). Fibronectin immunoreactivity in ARPE19-ECM
was localized to a similar network of fibrils (Fig. 2), however laminin-α5
immunoreactivity was found to be sparse and punctate (Fig. 1). Since
laminin-α5 is localized to the RBL of BrM, these results suggest the RBL
may be partially removed by the decellularization process. Supporting
this hypothesis, discrete spots of laminin-α5 immunoreactivity were ob-
served when ARPE19 cells were immunostained prior to decellulariza-
tion (Supp Fig. 4E).
Although fibronectin and laminin are found in both inner and outer
layers of BrM, vitronectin has been localized to the ICL [6] suggesting
this ECM protein may be supplied by RPE cells. In this study, abundant
vitronectin deposition was observed in ARPE19-ECM (Supp Fig. 3). In
contrast, collagen VI, which is localized to the OCL and elastic layer
of BrM, and elastin, which forms the middle elastic layer of BrM [7],
were not detected in ARPE19-ECM (Fig. 1). Collagen IV and V, which
are found in the collagenous layers and basal lamina on both sides of
the elastic layer [6], were both present in ARPE19-ECM (Fig. 1). The
presence of vitronectin and the absence of collagen VI and elastin sug-
gest that ARPE19 cells deposit a matrix resembling the inner layers
(ICL-RBL) of BrM. Additionally, both vitronectin and fibronectin pro-
teins were shown to undergo retinal specific post-translational modifi-
cations during ARPE19-ECM deposition (Fig. 3). Together, these results
demonstrate that ARPE19-ECM provides a surface substrate that mimics
the structural and molecular properties of BrM in the retina.
4.3. ARPE19-ECM promotes RPE differentiation
To examine the effect of ARPE19-ECM on primary human RPE cells,
freshly isolated human RPE cells were seeded onto geltrex, vitronectin
or ARPE19-ECM surfaces and cultured them for 1 month in DMEM with
10% FCS. Under these conditions, adult human RPE cells adhered to
surfaces coated with geltrex or recombinant vitronectin, however long
term culture on these substrates led to the loss of pigmentation in mono-
layers (Fig. 4). RPE cell survival on vitronectin was particularly poor,
with cells failing to achieve confluence despite high cell seeding densi-
ties. It is notable that although the vitronectin used for coating plates in
this study contained numerous vitronectin immunoreactive bands, the
10 kDa clipped vitronectin peptide was not present (Fig. 3B). In reti-
nal, RPE and ARPE19 cell extracts only the 10 kDa vitronectin band
was detected, indicating the clipped isoform represents a retinal spe-
cific post-translational modification of this protein. In contrast with gel-
trex or vitronectin, human primary RPE cells seeded onto ARPE19-ECM
maintained a mature, pigmented phenotype for over 1 month (Fig. 4).
Together, these results demonstrate that ARPE19-ECM provides a tis-
sue-specific microenvironment that promotes pigmentation during pri-
mary RPE cell culture.
Interestingly, previous studies demonstrated enhanced RPE differen-
tiation on ECM derived from bovine corneal endothelial cells (BCEC)
compared with RPE cell-derived ECM. [3] In this study, ECM was de-
posited over 1 week of culture and BCECs deposited more ECM protein
during this period than RPE cells. Here the deposition of ECM proteins
by ARPE19 cells was shown to increase over 1–4 weeks in culture (Supp
Fig. 3). Fibronectin was rapidly deposited on the cell culture floor, while
other ECM proteins, such as laminin-α5 and vitronectin took longer to
accumulate in the matrix. In addition, fibronectin underwent post-trans-
lational modifications that increased its mobility during SDS-PAGE, sug-
gesting maturation of the ARPE19-ECM occurs with extended culture
times (Fig. 3A). These results suggest that ARPE19 cells require at least
2–3 weeks to accumulate ECM proteins and develop a mature basement
membrane. Therefore, it is possible that the differences in RPE cell dif-
ferentiation previously reported on BCEC and RPE cell-derived ECM re-
flect differences in the rates of ECM protein production and deposition
between the two cells lines. In the present study, laminin-α5 was not de-
tected in ARPE19-ECM after 1 week of culture (Supp Fig. 3), therefore
ARPE19-ECM surfaces were produced over 2 weeks to allow accumula-
tion of this and other ECM proteins in the matrix.
To further examine the RPE promoting properties of ARPE19-ECM,
human iPSC were seeded onto geltrex or ARPE19-ECM and cultured
in DMEM with 10% FCS to induce spontaneous differentiation. Expres-
sion of the ocular transcription factors PAX6, MITF and OTX2 was in-
duced on both surfaces after 2 weeks of culture, however expression of
RPE65, a marker of RPE cells, was significantly increased when cells
were cultured on ARPE19-ECM compared with geltrex (Fig. 5C). After 4
weeks, iPSC cultured on geltrex adopted a fibroblastic, non-pigmented
phenotype, while iPSC cultured on ARPE19-ECM formed three dimen-
sional, pigmented spheres and polygonal RPE-like monolayers (Fig. 5A).
These results indicate ARPE19-ECM contains signals that promote RPE
cell differentiation from pluripotent stem cells. Together, the results pre-
sented here indicate that the manufacture of retinal-specific microenvi-
ronments using cultured cell lines provides an efficient and inexpensive
method for inducing RPE cell differentiation and enriching RPE cell cul-
tures.
4.4. Conclusions
In summary, our results demonstrate a method for producing a
BrM-like surface for the culture of RPE cells. ARPE19-ECM contains
physical and molecular cues found in BrM and promotes the acquisition
and maintenance of the RPE phenotype. ARPE19-ECM could be pro-
duced under serum-free conditions and on alternative substrates, includ-
ing fibrin gels and silk fibroin (Supp Fig. 5), demonstrating the utility
of this method for surfacing substrates with the potential for use in RPE
cell replacement therapies.
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